The Central Drug Standard Control Organisation (CDSCO) has decided to initiate an online portal for Registration and import license application for the medical device. This online registration / submission of medical devices portal should start from March, in which we can apply, track the status of application, document submitted, license to import the medical device into India through a application reference number. The portal is handled by SUGAM which is in tie up with the Union health ministry’s e-governance initiative.
Presently the portal has started working on granting license to import the drugs (registration certificate for drugs in India) and import license for the drugs industry. It will provide the benefits shortly to the medical device industry of India for granting of registration certificate and renewal of the license for medical devices. The eligible applicants are the importer, corporate, Indian Authorized Agents, foreign enterprise holding Indian subsidiary and manufacturing unit can also apply for the licence. You could find the important licenses and forms to keep in mind in our blog section.
Drug Controller General India (DCGI) Dr G N Singh said that, “The portal will be launched soon and the start up will take the e-governance to a new level. By which the stakeholders and patients get their license and medicines without any delay. Regulatory requirements need to be set to minimal standards so that there wont be any stopping factor in the industry to affect any of the work hence the decision to launch the online portal was taken”.
Applicants should register themselves in the portal to login with valid credentials and can apply for the license. The portal has a fresh user interface to submit user applications, supporting documents and can communicate to the queries of the CDSCO officials.
Other News
India Medical Device Pricing Strategy: Ensuring Growth & Affordability
India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]
Read MoreImports of High-Value Medical Equipment
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC Committee: Pioneering Medical Approvals
New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
TUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More
